Market Overview

Intercept Pharma Announces OCA Well Tolerated, Says 5 Patients Met Primary Efficacy Point

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News FDA

 

Most Popular

Related Articles (ICPT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters